חזרה לתוצאות החיפוש

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Prostatic Neoplasms, Castration-Resistant

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Border Medical Oncology Research Unit / The Border Cancer Hospital, Albury, New South Wales, Australia

    Contact: Study coordinator (Craig Underhill) · cunderhill@bordermedonc.com.au
    Contact: Study coordinator (Jacqui McBurnie) · jacqui.mcburnie@bordermedonc.com.au · +61260641508
    Contact: Principal Investigator (Christopher Steer, A/Prof)

  • Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia

    Contact: Study coordinator (Jacquie Harvey, MBBS FRACP) · Jacquie.Harvey@lh.org.au · +61 2 8514 0194
    Contact: Principal Investigator (Prof. Lisa Horvath, Horvath)

  • St George Hospital, Kogarah, New South Wales, Australia

    Contact: Study coordinator (Raymund Austria) · RaymundGino.Austria@health.nsw.gov.au · +61 2 9113 1111
    Contact: Principal Investigator (Carole Harris, dr.)

  • Calvary Mater Newcastle, Newcastle, New South Wales, Australia

    Contact: Study coordinator (Kim Adler) · kim.adler@calvarymater.org.au · +612 40143282
    Contact: Principal Investigator (Howard Chan, Dr.)

  • Genesis Care North Shore, St Leonards, New South Wales, Australia

    Contact: Study coordinator (Grace Till) · Grace.Till@genesiscare.com · +61 474 164 541
    Contact: Principal Investigator (Dr. Laurence Krieger, MBChB, FRACP)

  • Sydney Adventist Hospital, Wahroonga, New South Wales, Australia

    Contact: Study coordinator (Nina Singh) · nina.singh@sah.org.au · +61 2 9480 6280
    Contact: Principal Investigator (Prof. Gavin Marx)

  • Sunshine Coast University Hospital, Birtinya, Queensland, Australia

    Contact: Study coordinator (Christine Cook) · SC-Oncologytrials@health.qld.gov.au · +61752020651
    Contact: Principal Investigator (Andrew Schmidt, Dr.)

  • Mater Hospital Brisbane, South Brisbane, Queensland, Australia

    Contact: Study coordinator (Donna Harvey) · Donna.Harvey@mater.org.au
    Contact: Principal Investigator (Dr. Niara Oliveira)

  • Royal Adelaide Hospital, Adelaide, South Australia, Australia

    Contact: Study coordinator (Hsiang Tan) · hsiang.tan@sa.gov.au · +6170742336

  • ICON Cancer Centre, Adelaide, South Australia, Australia

    Contact: Study coordinator (Sue Yeend) · sue.yeend@icon.team · +61884740220
    Contact: Principal Investigator (Craig Gedye, A/Prof)

  • Eastern Health Box Hill, Box Hill, Victoria, Australia

    Contact: Study coordinator (Kiko Liu) · kiko.liu@monash.edu · +61390952465
    Contact: Principal Investigator (Iris Tung, dr.)

  • Fiona Stanly Hospital, Murdoch, Western Australia, Australia

    Contact: Study coordinator (Caroline Stone) · caroline.stone@health.wa.gov.au · +61 8 6152 6530
    Contact: Principal Investigator (Dr Thomas Ferguson)

  • Radboud Univeristy Medical Centre, Nijmegen, Gelderland, Netherlands

    Contact: Study coordinator (Inge van Oort, MD PhD) · inge.vanoort@radboudumc.nl · 0031243613735
    Contact: Principal Investigator (Inge van Oort, MD PhD)

  • Spaarne Gasthuis, Hoofddorp, North Holland, Netherlands

    Contact: Study coordinator (Aart Beeker, MD PhD) · abeeker@spaarnegasthuis.nl · 0031232245802
    Contact: Principal Investigator (Aart Beeker, MD PhD)

  • Isala Ziekenhuis, Zwolle, Overijssel, Netherlands

    Contact: Study coordinator (Metin Tascilar, MD PhD) · m.tascilar@isala.nl
    Contact: Principal Investigator (Metin Tascilar, MD PhD)

  • Groene Hart Ziekenhuis, Gouda, South Holland, Netherlands

    Contact: Study coordinator (Wendy van der Deure, MD PhD) · Wendy.van.der.Deure@ghz.nl · 0031182505005
    Contact: Principal Investigator (Wendy van der Deure, MD PhD)

  • Leids Universitair Medisch Centrum, Leiden, South Holland, Netherlands

    Contact: Study coordinator (Tom van der Hulle, MD PhD) · t.van_der_hulle@lumc.nl · 0031715263464
    Contact: Study coordinator (Amy Rieborn, MD) · a.rieborn@lumc.nl · 0031652887817
    Contact: Principal Investigator (Tom van der Hulle, MD PhD)

  • Meander Medical Centre, Amersfoort, Utrecht, Netherlands

    Contact: Study coordinator (Joyce van Dodewaard - de Jong, MD PhD) · jm.van.dodewaard@meandermc.nl · 0031338507278
    Contact: Principal Investigator (Joyce van Dodewaard - de Jong, MD PhD)

  • University Medical Center Groningen, Groningen, Netherlands

    Contact: Study coordinator (Michel van Kruchten, MD PhD) · m.van.kruchten@umcg.nl
    Contact: Principal Investigator (Michel van Kruchten, MD PhD)
מובילי המחקר

  • Tom van der Hulle, MD

    Principal Investigator

    Leiden University Medical Center

  • A/Prof. Craig Gedye, MBChB,FRACP

    Study Chair

    Australian and New Zealand Urogenital and Prostate Cancer Trials Group

  • Dr. Laurence Krieger, MBChB,FRACP

    Principal Investigator

    Australian and New Zealand Urogenital and Prostate Cancer Trials Group

  • Dr. Amy Rieborn

    Principal Investigator

    Leiden University Medical Center

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)